Pediatrix appoints Sylvia Young as independent director effective May 12

Pediatrix Medical Group, Inc.

Board size increased to nine; Ms. Young appointed as independent director.
Young recently served as President/CEO of HCA Continental Division, retired March 2023.
She will receive standard non-employee director compensation and enter indemnification agreement.
No material transactions or arrangements with Young; no committee assignments yet.
Appointment effective May 12, 2023; press release issued May 4.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sylvia Young

Director

MD · Pediatrix Medical Group, Inc.

Effective: 2023-05-12
Filed: May 4, 2023, 7:59 PM ET

increased the size of the Company’s Board to nine (9) members and appointed Ms. Sylvia Young to serve as a Director of the Company, each effective as of May 12, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sylvia Young was appointed as Director at Pediatrix Medical Group, Inc..

Action: appointed
Role: Director

Exact text from the filing

increased the size of the Company’s Board to nine (9) members and appointed Ms. Sylvia Young to serve as a Director of the Company, each effective as of May 12, 2023.

View on SEC.gov

Pediatrix Medical Group, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-017882

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.